Recent advances of anti-cancer therapies including the use of cell-penetrating peptides

Curr Opin Pharmacol. 2019 Aug:47:8-13. doi: 10.1016/j.coph.2019.01.003. Epub 2019 Feb 13.

Abstract

Cancer is one of the major growing public health problems making the development of new anti-cancer treatment strategies still compulsory. Conventionally used chemotherapies are quite often associated with severe side effects. One reason is limited cell-permeability of the used drugs resulting in only poor overall bioavailability. During the last thirty years, cell-penetrating peptides (CPPs) have extensively been studied as efficient vehicles for several classes of cargos, and the development of novel therapeutic applications including CPPs has gained a major role in current cancer research. This review summarizes recent trends in CPP-mediated cargo delivery with a future impact on anti-cancer therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Cell-Penetrating Peptides / administration & dosage*
  • Drug Delivery Systems
  • Humans
  • Nanostructures / administration & dosage
  • Neoplasms / drug therapy*
  • Oligonucleotides / administration & dosage

Substances

  • Antineoplastic Agents
  • Cell-Penetrating Peptides
  • Oligonucleotides